U.S. Consumer Durables Stock News

Avidity Biosciences (RNA) has quietly turned into a strong performer, with the stock up sharply this year as investors warm to its RNA therapeutic platform and advancing muscular dystrophy pipeline. See our latest analysis for Avidity Biosciences. That surge in optimism is showing up in the numbers, with a roughly 49 percent 3 month share price return feeding into a powerful 129 percent year to date share price gain and an eye catching 3 year total shareholder return above 550 percent. This...

If you have been wondering whether Kenvue is a beaten down bargain or a value trap at around $16.93, you are not alone. This article is going to walk through the numbers with you. Despite a modest 0.3% move over the last month, the stock is still down 2.4% in the past week and roughly 20.4% year to date, leaving it about 22.8% lower than it was a year ago and squarely on value investors radar. Those swings have played out against a backdrop of Kenvue continuing to carve out its identity as a...

If you are wondering whether Five Below is still a bargain after its big run, or if you have already missed the move, this breakdown will help you assess whether the current price really matches the story. The stock has climbed about 5.0% over the last week, 13.7% over the past month, and 74.8% year to date, with a 53.6% gain over the last year, even though 3-year and 5-year returns have been more muted. Recent attention has focused on Five Below's aggressive store expansion strategy and its...

Microvast Holdings recently highlighted growing commercial traction for its advanced battery technologies, including real-world deployments and expanding revenue streams across key markets. Partnerships with industrial players such as Škoda in EMEA have become an important proof point for Microvast’s technology, strengthening confidence in its execution capabilities beyond its core manufacturing base. We’ll now examine how this expanding Škoda-backed EMEA traction could reshape Microvast’s...

Veracyte (VCYT) just delivered a stronger than expected third quarter, topping earnings and revenue forecasts and lifting its full year revenue and adjusted EBITDA margin guidance, a combination that tends to reset investor expectations fast. See our latest analysis for Veracyte. That upbeat guidance lands after a strong run, with the share price up around 37 percent on a 90 day basis and supported by a 67 percent three year total shareholder return. This suggests momentum is building even...

RBC Bearings (RBC) has quietly turned into one of the stronger compounders in industrials, with the stock up roughly 16% over the past 3 months and nearly 50% year to date. See our latest analysis for RBC Bearings. At around $443.44 per share, RBC’s strong year to date share price return and hefty three year total shareholder return suggest momentum is still building as investors grow more comfortable paying up for its growth and margin profile. If RBC’s run has you thinking about where else...

In early December 2025, Encore Capital Group reported third quarter 2025 earnings per share that significantly beat market expectations, powered by stronger-than-anticipated collections, while Director Olle Laura completed a prearranged sale of 1,423 shares under a Rule 10b5-1 trading plan. The results spotlight how Encore’s collection performance is outpacing assumptions, reinforcing the importance of its operational execution and analytics-driven recovery model for investors. Next, we’ll...

If you are looking at Ondas Holdings and wondering whether the jaw dropping share price run has already priced in the opportunity, you are not alone. That is exactly what this article is going to unpack. The stock has rocketed, up 14.8% over the last week, 56.1% over the last month, 244.9% year to date, and an eye catching 1028.2% over the past year, which naturally raises questions about whether this is sustainable growth or froth. Much of this momentum has been underpinned by investor...

Wondering if Darling Ingredients at around $36 a share is a bargain or a value trap? You are not alone, and this breakdown is for investors trying to make sense of where it really stands. After a rough few years, the stock has quietly clawed back with a 12.2% gain over the last month and a 6.4% rise year to date, even though it is still down 41.4% over 3 years. That rebound has come as investors refocus on Darling's role in renewable feedstocks and sustainable materials, especially its...

Lufax Holding has renewed several core 2026 agreements, including its Account Management Framework Agreement and Financial Services Framework Agreement with Ping An Consumer Finance, and it has called an Extraordinary General Meeting for December 29, 2025, to seek shareholder input on these arrangements. By locking in these operational frameworks and formally engaging shareholders, the company is underscoring how central these partnerships are to its business model and future...

ThredUp (TDUP) has quietly turned into a tricky stock for resale fans and investors alike, with the share price swinging higher over the past week even as longer term performance remains mixed. See our latest analysis for ThredUp. That recent 15.96% 7 day share price return on ThredUp, taking the stock to 8.72 dollars, comes on top of a powerful year to date share price surge but choppy shorter term momentum, while the one year total shareholder return also looks impressive. If ThredUp has...

NVR (NVR) ticked higher after a rating upgrade, a move that usually reflects a more constructive view on its prospects and can nudge fresh attention toward the homebuilder and its mortgage operations. See our latest analysis for NVR. The upgrade comes after a choppy few months, with the share price at $7,538.08 and a recent 1 month share price return of nearly 4 percent. However, the year to date share price return and 1 year total shareholder return have been weaker, suggesting long term...

In recent months, AGCO has begun overhauling its dealer service model through its FarmerCore initiative, shifting toward an “Amazon-style” on-farm service network supported by mobile fleets, smaller dealer locations, and parts depots while also exiting low-margin grain and protein operations and pursuing company-wide cost savings. This transformation points to a deeper realignment of AGCO’s business toward higher-margin precision technology, more profitable aftermarket service, and a leaner...

In early December 2025, The Timken Company reported third-quarter revenue of US$1.16 billion, with higher sales, operating earnings, and cash flow than a year earlier, and presented at Goldman Sachs Industrials & Autos Week in London. Timken’s strong quarterly beat on analyst expectations came alongside repeated recognition for corporate responsibility and ethics, underscoring a blend of operational and ESG strengths. We’ll now examine how Timken’s stronger-than-expected quarterly earnings...

Recently, Moody's upgraded Kimco Realty to an A3 credit rating with a stable outlook, highlighting its high-quality, predominantly grocery-anchored portfolio, strong occupancy, and prudent balance sheet, while the company also raised guidance and increased its dividend on the back of solid operating results. This combination of a stronger credit profile and a higher dividend underscores Kimco's emphasis on balance sheet strength and income-focused returns, supported by diversified tenants...

In recent days, Antero Resources has experienced a sharp increase in options market activity, highlighting growing investor interest in its natural gas and NGLs business. This options surge suggests traders are actively positioning around potential volatility or company-specific developments, adding a fresh layer of complexity to how the stock is being viewed. Next, we’ll examine how this heightened options positioning could influence Antero Resources’ investment narrative built around...

Recently, Intellia Therapeutics disclosed serious liver-related safety events, including a case meeting Hy’s law criteria, in its lead in vivo CRISPR programs for hereditary angioedema and transthyretin amyloidosis, raising significant regulatory and clinical concerns. The heightened safety scrutiny is especially important because these programs target diseases that already have multiple approved treatments, potentially weakening Intellia’s competitive position and long-term pipeline...

Wondering if Lincoln National at around $42.74 is a bargain or a value trap? You are not alone, and we are going to unpack exactly what the market might be missing. The stock has climbed 3.9% over the last week and month, and it is now up 34.2% year to date and 31.3% over the past year, which signals that investor sentiment and expectations have shifted meaningfully. Recently, headlines have focused on Lincoln National's ongoing balance sheet repositioning and strategic initiatives to...

BioLife Solutions (BLFS) has given investors plenty to chew on after Q3, with an earnings beat, stronger revenue guidance for its cell processing platform, and a new biopreservation center opening in Bothell. See our latest analysis for BioLife Solutions. Even with the upbeat Q3 and the new biopreservation center signaling a long runway for its CGT tools, BioLife’s recent share price return has been slightly negative and its 1 year total shareholder return is modestly underwater, suggesting...

In late 2025, FIFA announced an expanded agreement with Globant to enhance its digital platforms and build a new mobile app to support multiple tournaments, while naming Globant a Tournament Supporter for the FIFA World Cup 2026 and FIFA Women's World Cup 2027. Coming alongside Globant’s Converge 2025 AI event and top-tier Salesforce recognition, this deeper FIFA collaboration highlights how the company is weaving together sports, cloud, and enterprise AI capabilities across its client...

Columbia Financial (CLBK) climbed about 4% after the Federal Reserve's recent rate cut lifted sentiment across community banks, a move that comes in addition to the company’s strong third quarter revenue growth. See our latest analysis for Columbia Financial. The latest move takes Columbia Financial’s 30 day share price return to just over 10%, and while the 1 year total shareholder return remains slightly negative, the recent momentum suggests investors are warming to its improving earnings...

Ellington Financial Inc. announced that its Board of Directors has declared monthly and quarterly dividends on its common and preferred shares, including a US$0.13 common dividend payable on January 30, 2026, and Series A–D preferred dividends ranging from US$0.390625 to US$0.593907 per share. These dividend affirmations, coming after a strong third quarter supported by robust net income, an expanded credit portfolio, and a US$400.00 million unsecured note issuance, highlight the company’s...

Confluent (CFLT) just delivered an upbeat third quarter, with revenue climbing around 19% and subscriptions accelerating across Confluent Cloud and Platform. This prompted management to lift full year guidance and lean harder into AI driven data streaming. See our latest analysis for Confluent. Despite the upbeat quarter, Confluent’s share price return over the past year is still negative. The 90 day share price return of 14.33% suggests momentum is tentatively rebuilding as investors...

The Paranovus Entertainment Technology Ltd. ( NASDAQ:PAVS ) share price has fared very poorly over the last month...